America is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing deals or commit to manufacturing in the US. Companies have a limited time to comply. This aims to lower prescription drug costs for Americans. Exemptions and reduced rates are available for those meeting specific criteria.